Wikidata

(Q82837990)

English

A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis

scientific article published on 06 December 2011

In more languages

Statements

title
A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22147649
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147649%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 January 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q82837990&oldid=2005506650"